Skip to main content
. 2019 Jun 28;18(3):2443–2447. doi: 10.3892/ol.2019.10540

Figure 1.

Figure 1.

Downregulation of lncRNA GATA6-AS distinguishes patients with MCL from healthy controls. (A) Compared with healthy controls, plasma expression levels of lncRNA GATA6-AS were significantly reduced in patients with MCL. (B) Downregulation of lncRNA GATA6-AS distinguished patients with MCL from healthy controls. *P<0.05. lncRNA GATA6-AS, long non-coding RNA GATA6 antisense RNA 1; MCL, mantle cell lymphoma.